Today: 10 April 2026
Subscribe

Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit shares traded around $190 on Oct. 17, down 4.3% for the day and off sharply from a mid-September record near $283. The stock remains up about 244% year-to-date and over 600% since its March 2024 IPO. Q2 revenue jumped 78% to $500 million, with net income at $89 million. Analyst consensus rates the stock a “Moderate Buy,” with a 12-month price target averaging $202.
17 October 2025
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences shares rose to $123 on October 17, 2025, up nearly 40% from a year ago, lifting its market value to about $150 billion. The company settled U.S. patent litigation over HIV drug Biktarvy, blocking generics until 2036. Its new HIV prevention shot Yeztugo is seeing strong uptake, and Moody’s raised Gilead’s outlook to “Positive.” Gilead also announced a $1.5 billion cell therapy deal with Pregene.
17 October 2025
··
Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems shares surged about 20% to $3.17 on Oct. 17, extending a 73% rally over the past month after the company previewed record Q3 revenue and major new contracts. Rekor won a $50M+ Georgia DOT deal, deployments with Caltrans and TxDOT, and a $1M South Carolina order. The price-to-sales ratio now matches the industry median as investors anticipate 19% revenue growth next year.
17 October 2025
··
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy shares jumped over 20% intraday on October 17 after reporting Q3 revenue of $947 million, down 17% year-over-year, and an adjusted net loss of $0.06 per share. Despite the rebound, LBRT remains about 40% lower year-to-date, closing at $11.94 on October 16. The company raised its quarterly dividend by 13% to $0.09 per share. Analyst price targets cluster around $13–$15 for the next year.
17 October 2025
····
Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin and the crypto market plunged on Oct. 10–11, 2025, erasing over $19 billion in leveraged positions after President Trump announced 100% tariffs on Chinese goods. Bitcoin fell nearly 10%, Ethereum 20%, and some altcoins up to 40%. Major exchanges like Binance faced outages and accusations of profiting from liquidations. On-chain data showed whales moved large sums just before the crash, fueling manipulation suspicions.
17 October 2025
····
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences said the FDA canceled a key meeting and imposed new trial demands for its lead drug zetomipzomib, delaying development by about two years. The company is now exploring a sale or merger and cutting costs. Shares jumped nearly 40% to $6 on Oct. 17. Kezar reported $90.2 million in cash as of Sept. 30 but faces higher expenses and extended a poison pill plan to 2026.
17 October 2025
··
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine shares jumped 25.5% to $93 on October 17, 2025, after the FDA granted a Commissioner’s National Priority Voucher for its lead drug, bitopertin. The company filed a New Drug Application for bitopertin in late September; with the voucher, an approval decision could come as soon as late December. Several analysts raised their price targets sharply following the FDA news.
17 October 2025
·
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Group (NASDAQ: NBIS) stock soared over 350% year-to-date, fueled by a $17.4 billion AI infrastructure deal with Microsoft in September that triggered a one-day 44% jump. Shares cooled to $114 on Oct. 17, down 7% amid heavy profit-taking. The company raised $1.3 billion recently to fund a $3 billion expansion of its AI cloud capacity. Q2 revenue surged 625% to $105.1 million, but Nebius remains unprofitable.
17 October 2025
···
Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Hims & Hers Health launched a menopause and perimenopause care program on its Hers platform Oct. 15, triggering a one-day stock surge of up to 16%. Shares quickly reversed, falling 11% to around $52–53 by Oct. 17. The company aims for $1 billion annual revenue in women’s health by 2026. Analysts remain divided, citing high valuation and volatile trading despite rapid revenue growth.
17 October 2025
·
Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial shares rose about 2% on Oct. 17 after posting Q3 profit of $548 million, up 23% from a year ago, and adjusted EPS of $0.63, beating forecasts. Revenue climbed 7% to $1.9 billion. The board raised the quarterly dividend 6% to $0.265 per share. Management trimmed full-year net interest income guidance but reported improved asset quality and steady deposit growth.
17 October 2025
··
VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX Holding Corp’s stock surged as much as 71% on Oct. 17 after announcing a General Services Administration contract, reaching a 30-month high near $29 before settling in the low $20s by midday. The deal designates VirnetX as an approved technology provider for U.S. government agencies, expanding federal market access. Market cap rose to about $75 million. CEO Kendall Larsen called the contract a “major step forward.”
17 October 2025
··
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce shares jumped nearly 4% to around $245 Friday after the company raised its 2030 revenue target above $60 billion, beating Wall Street estimates. Despite the rally, CRM remains down about 29% in 2025, lagging major peers and indexes. The new forecast excludes an $8 billion Informatica deal aimed at boosting AI capabilities. Investors remain split, with analyst targets ranging from $221 to $405.
17 October 2025
··
Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Holdings shares rose about 12% to $0.22 on Oct. 17 after announcing a binding term sheet with White Lion Capital for a Bitcoin Purchase Agreement. Pre-market trading saw the stock spike to $0.23. The company also revealed plans for a ¥10 billion fund with European partners to promote Asian media content. No Wall Street analysts cover BLMZ; AI models project modest further gains.
17 October 2025
··
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont Stock Skyrockets on Gold Boom: Record Highs, $100 B Milestone & Bold Forecasts

Newmont Corporation shares surged nearly 15% this week, pushing its market value above $100 billion for the first time. The rally follows gold prices hitting record highs above $4,300 per ounce amid geopolitical tensions and Fed rate cut expectations. Major banks raised price targets, with Bank of America setting a $115 target on October 16. Newmont reports Q3 earnings October 23, with analysts forecasting a 58% profit jump.
17 October 2025
··
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences shares jumped over 20% in pre-market trading Friday after receiving an FDA Commissioner’s National Priority Voucher for its lead drug, cytisinicline. The FDA also accepted Achieve’s New Drug Application for cytisinicline as a smoking cessation treatment, with a decision expected by June 2026. ACHV stock reached multi-month highs near $3 following the news. The company’s market cap is about $160 million.
17 October 2025
··
Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

Huntington Bancshares stock rose 2% to the mid-$15 range on Oct. 17, 2025, after Q3 net income jumped 22% to $629 million, beating estimates. Revenue reached $2.15 billion, with interest income up 11% and non-interest income up 20%. Average loans grew 9%, while net charge-offs stayed low at 0.22%. The bank is set to close its merger with Veritex Holdings on Oct. 20.
17 October 2025
·
1 … 1,651 1,652 1,653 1,654 1,655 … 1,847

Stock Market Today

  • ServiceNow Shares Slide 43% in Year, DCF Model Suggests Stock Is Undervalued
    April 9, 2026, 7:02 PM EDT. ServiceNow (NOW) stock has plunged 43% over the past year, closing recently at $89.81. Investors have grown cautious amid shifting sentiment in large-cap software and cloud sectors toward growth, cost discipline, and valuation reset. Despite the share price slide, a Discounted Cash Flow (DCF) analysis by Simply Wall St values ServiceNow shares at about $168.81, suggesting a nearly 47% undervaluation. The DCF model forecasts free cash flow rising from $4.45 billion last year to $9.49 billion by 2030. ServiceNow scores 2 out of 6 on a simple valuation check, indicating some risks. However, the DCF assessment implies significant upside potential for long-term investors eyeing the cloud-computing firm's recovery.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Go toTop